drugset / Trial / NCT02998099

A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.

NCT02998099

Phase 1 Completed 16 enrolled GlycoMimetics Incorporated
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the effect of age on PK, safety and tolerability of IV rivipansel.

Timeline

Start
2017-01
Primary completion
2017-02
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivipansel Small molecule Intravenous

Indications

No indication recorded.